Abilify Lawsuit Update
Abilify Trials Settled at Mediation
Abilify lawsuits allege the anti-psychotic medication is linked to compulsive gambling and other addictive behaviors and the drug companies failed to warn them about these “uncontrollable compulsive behaviors.” In fact, the drug labels in Europe and Canada warn of the pathological gambling risk, but failed to place this warning on the American labels. Prescribed to treat schizophrenia, bipolar disorder, depression, and Tourette syndrome, over 450 cases have been consolidated before Chief Judge M. Casey Rodgers in the Northern District of Florida in MDL 2734: In re: Abilify (Aripiprazole) Products Liability Litigation (Abilify MDL Case – Northern District of Florida) with Magistrate Judge Gary Jones. Abilify trials set for June 18, 2018 were settled at mediation before Special Master Cathy Yanni. Judge Casey Jones entered an order 876 – Order, Settlement of First Trial Pool Cases.pdf suspending the deadlines and staying further prosecution.